Medical Condition News

RSS

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire plc today announced that Natpara (parathyroid hormone) for injection is now available in the United States. The U.S. Food and Drug Administration approved Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism on January 23, 2015.

1 Apr 2015

New blood test promises to detect food allergies

A new blood test promises to predict which people will have severe allergic reactions to foods according to a new study led by Mount Sinai researchers and published online today in the The Annals of Allergy, Asthma & Immunology.

1 Apr 2015

New ERS and ATS statement highlights current state, future research directions in COPD

The European Respiratory Society and American Thoracic Society have published a statement describing the current evidence on the diagnosis, assessment and management of chronic obstructive pulmonary disease (COPD), identifying gaps in knowledge and making recommendations for the directions of future research.

1 Apr 2015

University of York student helps develop new drug release gel

A Chemistry undergraduate at the University of York has helped to develop a new drug release gel, which may help avoid some of the side effects of painkillers such as ibuprofen and naproxen.

1 Apr 2015

New research reveals effects of physician advice on weight loss

Patients advised to lose weight by their physicians dropped more pounds on average than those who didn't receive a recommendation, according to new research from the University of Georgia published in the journal Economics & Human Biology.

1 Apr 2015

MHIF investigator performs first atrial fibrillation ablation in U.S. using SMARTTOUCH SF catheter

Dr. Daniel Melby, an investigator at the Minneapolis Heart Institute Foundation, performed the first atrial fibrillation ablation in the U.S. using Biosense Webster's new THERMOCOOL SMARTTOUCH SF contact force sensing catheter as part of an FDA regulated safety trial (SMART-SF).

1 Apr 2015

Folic acid supplements can improve blood vessel dilation in older adults

Supplemental folic acid can enhance blood vessel dilation in older adults, according to Penn State researchers, suggesting that folic acid supplements may be an inexpensive alternative for helping older adults to increase skin blood flow during heat waves and reduce cardiovascular events.

1 Apr 2015

GEBN makes meaningful contributions to improve public health

As the scientific community gathers at Experimental Biology 2015, the Global Energy Balance Network is poised to make meaningful contributions to the broader community's efforts to improve public health. GEBN is a network of scientists from North America, Latin America and the Caribbean, Europe, Africa, Asia and Oceania who have banded together to further the understanding of the regulation of energy utilization by the body (energy balance) and apply this understanding to develop novel approaches to health and wellness.

1 Apr 2015

Researchers evaluate effects of integrating religious beliefs into depression therapy

For chronically ill patients with major depression, an approach to cognitive-behavioral therapy (CBT) that incorporates patients' religious beliefs is at least as effective as conventional CBT, suggests a study in the April issue of The Journal of Nervous and Mental Disease.

1 Apr 2015

Phone counseling can boost recovery, reduce pain in patients after spinal surgery

Research by Johns Hopkins scientists suggests that having a short series of phone conversations with trained counselors can substantially boost recovery and reduce pain in patients after spinal surgery.

1 Apr 2015

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Lung diseases like emphysema and pulmonary fibrosis are common among people with malfunctioning telomeres, the “caps” or ends of chromosomes. Now, researchers from Johns Hopkins say they have discovered what goes wrong and why.

1 Apr 2015

Selvita commences IND-enabling studies for its first oncology drug candidate

Selvita, the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate.

1 Apr 2015

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences, Inc. today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation.

1 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015

Patient's own skin cells may hold key to new treatments for neurological diseases

A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.

31 Mar 2015

New osteoporosis drug may also be useful for treating brittle bone disease

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating bone disorder that that is present from birth.

31 Mar 2015

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

The physicians at Orthopaedic & Spine Center have put together an information guide – Surgery Isn't Always the Answer. The resource discusses conservative treatment options for those who suffer from hip, knee, and spine pain. The guide also shares information on the benefits of early diagnosis and minimally-invasive surgical treatments.

31 Mar 2015

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Northwestern Medicine recently launched a multidisciplinary center dedicated to the comprehensive treatment of patients battling Huntington's disease. The new center will focus on both patient care and research of the inherited disease that causes the progressive breakdown of nerve cells in the brain.

31 Mar 2015

Study suggests possible role for caffeine in AD treatment

The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

31 Mar 2015

Good Samaritan Hospital's Stroke Program certified as primary stroke center

Good Samaritan Hospital's Stroke Program has attained The Joint Commission's Gold Seal of Approval® and the American Heart Association/American Stroke Association's Heart-Check mark as a certified primary stroke center. The recognition means the Stroke Program has met The Joint Commission's standards for providing stroke care.

31 Mar 2015

Medical Condition News

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

New blood test promises to detect food allergies

New ERS and ATS statement highlights current state, future research directions in COPD

University of York student helps develop new drug release gel

New research reveals effects of physician advice on weight loss

MHIF investigator performs first atrial fibrillation ablation in U.S. using SMARTTOUCH SF catheter

Folic acid supplements can improve blood vessel dilation in older adults

GEBN makes meaningful contributions to improve public health

Researchers evaluate effects of integrating religious beliefs into depression therapy

Phone counseling can boost recovery, reduce pain in patients after spinal surgery

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Selvita commences IND-enabling studies for its first oncology drug candidate

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Patient's own skin cells may hold key to new treatments for neurological diseases

New osteoporosis drug may also be useful for treating brittle bone disease

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Study suggests possible role for caffeine in AD treatment

Good Samaritan Hospital's Stroke Program certified as primary stroke center

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News